Super User

LMX4 Slider Banner NO CTA

LMX4® is a fast1, effective1,2, well tolerated2,3 topical local anaesthetic that works in just 30 minutes. That’s half the time required in comparison to lignocaine/prilocaine preparations like Emla® and Numit. LMX4® can be used in all age groups including neonates for a wide range of procedures.

Lignocaine preparations are commonly used by physicians and other health care professionals to numb the skin prior to performing cosmetic procedures, obtaining blood specimens, and other such procedures. LMX4® is indicated for skin procedures, including insertion of IV catheters and blood sampling for adults and children 2 years of age and over. The active ingredient in LMX4® is 4% lignocaine. It also contains benzyl alcohol 1.5% as a preservative.

Always read the label and use only as directed.
Please review full Data Sheet before prescribing.

Super User


Be proactive and protect yourself as well as your patients.

HEALTH CARE PROFESSIONALS including nurses, medical providers, and therapists who work in General Practices and Medical Facilities face a difficult task of managing the complex conditions affecting a person while simultaneously monitoring them for signs and symptoms of infections.

hand hygiene

Arm yourself with our Infection Protection Toolkit.

 cutan  CAH Isolation Gowns
 CAH Respirator  CAH Exam Gloves


Super User

Clinical references:

1. Douek M, Klass J, Monypenny I, et al. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Ann Surg Oncol. 2014;21:1237–45.

2. Thill M, et al. The Central-European SentiMag study: sentinel lymph node biopsy with super paramagnetic iron oxide (SPIO) vs. radioisotope. Breast 2014;23:175–9.

3. Rubio IT, et al. The super paramagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Eur J Surg Oncol. 2015;41:46–51.

4. Pinero-Madrona A, et al. Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: a comparative non-inferiority study. Eur J Surg Oncol. 2015;41:991–7.

5. Ghilli M, et al. The supramagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment. Eur J Cancer Care (Engl). 2015. doi:10.1111/ ecc.12385

6. Houpeau JL, et al. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial. J Surg Oncol. 2016 Jan 12. doi: 10.1002/ jso.24164

7. Teshome M, Wei C, Hunt KK, et al. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Metaanalysis. Ann Surg Oncol. 2016 Feb 18.